InterValve

About:

InterValve develops medical devices and technology for the catheter-based treatment of calcified aortic valve stenosis.

Top Investors: Oxford Finance LLC

Description:

InterValve Inc. develops medical devices/technology for the catheter-based treatment of calcified aortic valve stenosis. It develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded in 2008 and is based in Minnetonka, Minnesota.

Total Funding Amount:

$14.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minnetonka, Minnesota, United States

Founded Date:

2008-01-01

Contact Email:

quality(AT)c.com

Founders:

Robert S. Schwartz, Robert Van Tassel, Wesley Pedersen

Number of Employees:

11-50

Last Funding Date:

2015-01-21

IPO Status:

Private

Industries: